ACTRN12609000080224招募中2 期
A Double-Blind, Placebo-controlled Crossover Clinical Trial of Desmopressin for the Treatment of Orthostatic Hypotension and Nocturia in Parkinson’s Disease
John O'Sullivan0 个研究点目标入组 20 人开始时间: 2009年2月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 30 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Parkinson's disease
- •Orthostatic hypotension (blood pressure drop with standing)
- •A need to empty the bladder 2 or more times at night
排除标准
- •History of renal failure, congestive heart failure, or cirrhosis
- •A history of low blood sodium
研究者
相似试验
进行中（未招募）
1 期
A study to explore the benefits of AUT00063 in adults receiving Cochlear ImplantEUCTR2015-003929-34-GBAutifony Therapeutics Limited15
进行中（未招募）
1 期
A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy and Safety of Fluasterone Buccal Tablet in the Control of Hyperglycemia in Adults with Endogenous Cushing’s SyndromeCushing SyndromeCTIS2023-508322-10-00Sterotherapeutics LLC24
进行中（未招募）
不适用
A placebo-controlled, double-blind, cross-over study with rupatadine 10 mg in 30 mosquito-bite allergic adult subjectsRupatadiini-antihistamiini hyttyspistoallergiassa - Rupatadiini-antihistamiini hyttyspistoallergiassamosquito-bite allergic adultsEUCTR2005-004422-50-FIJ.Uriach y Compania S.A.,30
已完成
不适用
A Double Blinded, Placebo Controlled, Crossover Infusion Study of Respiratory Pharmacodynamics of ENA-001 in Conjunction with Propofol, Hypoxia, and HypercapniaNL-OMON50050Enalare Therapeutics Inc.12
进行中（未招募）
1 期
A double-blind, placebo-controlled crossover trial to quantify the effects of sibutramine on energy intake and energy expenditure in obese subjects during a test meal - Sibutramine effects on energy balance in obesityObesity defined as BMI > 30 kg /m2Classification code 10029883EUCTR2005-002080-88-GBAintree Hospitals NHS Trust and University of Liverpool36